RECITALSRegistration Rights Agreement • January 22nd, 2007 • Bionovo Inc • Pharmaceutical preparations • California
AGREEMENT OF MERGER AND PLAN OF REORGANIZATIONMerger Agreement • April 8th, 2005 • Lighten Up Enterprises International Inc • Books: publishing or publishing & printing • Delaware
RECITALS:Assignment and Assumption Agreement • June 3rd, 2005 • Lighten Up Enterprises International Inc • Pharmaceutical preparations • California
BIONOVO, INC. WARRANT TO PURCHASE SHARES OF COMMON STOCK ====================== ========================================================== ==================== ============================================================ THIS SECURITY AND THE...Warrant Agreement • July 5th, 2005 • Bionovo, Inc. • Pharmaceutical preparations • New York
Exhibit 10.1 BIONOVO, INC. SUBSCRIPTION AGREEMENT SUBSCRIPTION AGREEMENT made as of this ____ day of _________ 2005, between Bionovo, Inc., a Delaware corporation (the "COMPANY"), and the undersigned subscriber (the "SUBSCRIBER"). All terms not...Subscription Agreement • May 11th, 2005 • Lighten Up Enterprises International Inc • Books: publishing or publishing & printing • California
WITNESSETHAcquisition Agreement • November 7th, 2002 • Lighten Up Enterprises International Inc • Utah
EXHIBIT 10.5 REGISTRATION RIGHTS AGREEMENT ----------------------------- This Registration Rights Agreement (this "Agreement") is made and entered into as of this __ day of September, 2004 by and between BIONOVO, INC. (the "Company"), and the...Registration Rights Agreement • June 3rd, 2005 • Lighten Up Enterprises International Inc • Pharmaceutical preparations • New York
EXCHANGE AGREEMENT BY AND BETWEEN LIGHTEN UP ENTERPRISES INTERNATIONAL, INC. MARY E. ROSS and GARY C. LEWIS THIS AGREEMENT is made and entered into by and between Lighten Up Enterprises International, Inc., ("Lighten Up) a Nevada corporation, Gary C....Exchange Agreement • September 16th, 2005 • Bionovo, Inc. • Pharmaceutical preparations • Nevada
EXHIBIT 10.20 This is an agreement to sublets property according to the terms specified below. The sublessor agrees to sublet, and the subtenant agrees to take the premises described below. Both parties agree to keep, perform, and fulfill the...Sublease Agreement • September 16th, 2005 • Bionovo, Inc. • Pharmaceutical preparations
EXHIBIT 10.7 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this "AGREEMENT") is made and entered into as of July 1, 2004, by and between Bionovo, Inc., a Delaware corporation (the "COMPANY"), and Isaac Cohen ("EXECUTIVE"). The parties agree as...Employment Agreement • June 3rd, 2005 • Lighten Up Enterprises International Inc • Pharmaceutical preparations • California
BETWEENOffice Lease • September 16th, 2005 • Bionovo, Inc. • Pharmaceutical preparations • California
SUBLEASESublease • September 16th, 2005 • Bionovo, Inc. • Pharmaceutical preparations
BIONOVO, INC.Securities Agreement • January 22nd, 2007 • Bionovo Inc • Pharmaceutical preparations • California
ContractRegistration Rights Agreement • July 7th, 2010 • Bionovo Inc • Pharmaceutical preparations • Illinois
EX-1 AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (the "MERGER AGREEMENT") is made and entered into by and between Lighten Up Enterprises International, Inc., a Nevada corporation ("LIGHTEN UP"), and Bionovo, Inc., a Delaware...Merger Agreement • June 3rd, 2005 • Lighten Up Enterprises International Inc • Pharmaceutical preparations • Delaware
FIRST AMENDMENT TO REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 13th, 2006 • Bionovo Inc • Pharmaceutical preparations • California
BIONOVO, INC.Subscription Agreement • January 22nd, 2007 • Bionovo Inc • Pharmaceutical preparations • Virginia
RECITALSRegistration Rights Agreement • May 11th, 2005 • Lighten Up Enterprises International Inc • Books: publishing or publishing & printing • California
BIONOVO, INC. PLACEMENT AGENCY AGREEMENT October 1, 2010Placement Agency Agreement • October 4th, 2010 • Bionovo Inc • Pharmaceutical preparations • New York
30,031,200 Shares Warrants to Purchase 15,015,600 Shares BIONOVO, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 2nd, 2011 • Bionovo Inc • Pharmaceutical preparations • New York
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • July 7th, 2010 • Bionovo Inc • Pharmaceutical preparations • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of July 6, 2010 by and between BIONOVO, INC. a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
7,000,000 Shares of Common Stock and Warrants to Purchase 3,500,000 Shares of Common Stock BIONOVO, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • November 6th, 2007 • Bionovo Inc • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 4th, 2012 • Bionovo Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (“Agreement”) is entered into and effective as of December 30, 2011 (“Effective Date”), by and among Bionovo, Inc., a Delaware corporation (“Company”), and Socius CG II, Ltd., a Bermuda exempted company (including its designees, successors and assigns, “Investor”).
LEASE by and between BMR-BRIDGEVIEW TECHNOLOGY PARK LLC, a Delaware limited liability company and BIONOVO, INC., a Delaware corporationLease Agreement • May 11th, 2011 • Bionovo Inc • Pharmaceutical preparations
Dates Square Feet of Rentable Area Base Rent per Square Foot of Rentable Area Monthly Base Rent Annual Base Rent Months 1-12 15,000 $1.25 monthly $ 18,750 $ 225,000 Months 13-24 25,000 $1.29 monthly $ 32,250 $ 387,000 Months 25-36 35,000 $1.33 monthly $ 46,550 $ 558,600 Months 37-48 51,472 $1.45 monthly $ 74,634.40 $ 895,612.80 Months 49-60 51,472 $1.50 monthly $ 77,208 $ 926,496 Months 61-72 51,472 $1.55 monthly $ 79.781.60 $ 957,379.20 Months 73-84 51,472 $1.65 monthly $ 84,928.80 $ 1,019,145.60 Months 85-96 51,472 $1.75 monthly $ 90,076 $ 1,080,912 Months 97-108 51,472 $1.85 monthly $ 95,223.20 $ 1,142,678.40 Months 109-120 51,472 $1.95 monthly $ 100,370.40 $ 1,204,444.80
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • January 27th, 2012 • Bionovo Inc • Pharmaceutical preparations • California
This AGREEMENT, entered into as of January 23, 2012 (the “Agreement”), by and between Bionovo, Inc., a Delaware corporation, with its principal office at 5858 Horton Street, Suite 400, Emeryville, CA 94608 (the “Company”), and Mary Tagliaferri (the “Executive”).
RECITALS:Landlord Consent to Sublease • September 16th, 2005 • Bionovo, Inc. • Pharmaceutical preparations
EXHIBIT 10.11 * Portions of this document have been omitted and are subject to a request for confidential treatment with the Securities and Exchange Commission. LICENSING & TECHNOLOGY TRANSFER AGREEMENT BIONOVO INC. UNITED BIOTECH CORPORATION NOVEMBER...Licensing & Technology Transfer Agreement • October 19th, 2005 • Bionovo, Inc. • Pharmaceutical preparations • California
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 9th, 2008 • Bionovo Inc • Pharmaceutical preparations • California
This Amended and Restated Executive Employment Agreement (“Agreement”) is made by and between Bionovo, Inc. (the “Company”) and Isaac Cohen (“Executive”), effective as of January 1, 2008 (the “Effective Date”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 13th, 2009 • Bionovo Inc • Pharmaceutical preparations • California
This Amended And Restated Executive Employment Agreement (“Agreement”), originally made by and between Bionovo, Inc. (the “Company”) and Isaac Cohen (“Executive”), effective as of January 1, 2008 (the “Effective Date”), is hereby amended and restated in its entirety effective as of January 1, 2008 to read as follows:
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 12th, 2012 • Bionovo Inc • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of March 12, 2012, by and among Bionovo, Inc., a Delaware corporation, with headquarters located at 5858 Horton Street, Suite 400, Emeryville, California 94608 (the "Company"), and the investors listed on the Schedule of Buyers attached hereto (individually, a "Buyer" and collectively, the "Buyers").
FITZSIMONS REDEVELOPMENT AUTHORITY AMENDMENT TWO TO SPACE LEASESpace Lease • May 8th, 2007 • Bionovo Inc • Pharmaceutical preparations
THIS AMENDMENT TWO TO SPACE LEASE (this “Amendment”) is entered into as of the _____________ day of ________________, 2007, by and between Fitzsimons Redevelopment Authority (“Landlord”) a governmental entity created by the City of Aurora, Colorado and the Regents of the University of Colorado, whose address or principal place of business is 12635 East Montview Blvd., Suite 100, Aurora, Colorado, 80045, and BioNovo, Inc. (“Tenant”).
EXHIBIT 10.14 ADDENDUM TO SUBLEASE This Addendum to Sublease (the "Addendum") is entered into as of this 20th day of April, 2004 by and between Geac Enterprise Solutions, Inc . (successor-in interest to Extensity, Inc.), a Georgia corporation...Sublease • September 16th, 2005 • Bionovo, Inc. • Pharmaceutical preparations
DAWSON JAMES SECURITIES, INC.Engagement Letter • September 30th, 2009 • Bionovo Inc • Pharmaceutical preparations
This letter amends the letter agreement between Bionovo, Inc. and Dawson James Securities, Inc. (“DJSI”) dated September 10, 2009, as amended September 23, 2009 and September 28, 2009 (as amended, the “Engagement Letter”) as follows:
FORM OF WARRANT BIONOVO, INC. Warrant To Purchase Common StockWarrant Agreement • March 12th, 2012 • Bionovo Inc • Pharmaceutical preparations • New York
Bionovo, Inc., a Delaware corporation (the "Company"), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [BUYER], the registered holder hereof or its permitted assigns (the "Holder"), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, at any time or times on or after the Issuance Date (the "Initial Exercisability Date"), but not after 11:59 p.m., New York time, on the Expiration Date, (as defined below), Five Million Seven Hundred Forty Two Thousand Nine Hundred Twenty Two (5,742,922) fully paid nonassessable shares of Common Stock, subject to adjustment as provided herein (the "Warrant Shares"). Except as otherwise defined herein, capitalized terms in this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, this "Warrant"), shall have the meanings
DAWSON JAMES SECURITIES, INC.Engagement Letter • September 30th, 2009 • Bionovo Inc • Pharmaceutical preparations
This letter amends the letter agreement between Bionovo, Inc. and Dawson James Securities, Inc. (“DJSI”) dated September 10, 2009, as amended September 23, 2009 (as amended, the “Engagement Letter”) as follows:
